Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging

Radiology

Volumn 241, Issue 2, 2006, Pages 449-458

  Fütterer, Jurgen J ^a   Heijmink, Stijn W T P J ^a   Scheenen, Tom W J ^a   Veltman, Jeroen ^a   Huisman, Henkjan J ^a   Vos, Pieter ^a   Hulsbergen Van De Kaa, Christina A ^a   Witjes, J Alfred ^a   Krabbe, Paul F M ^a   Heerschap, Arend ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; QUANTITATIVE DIAGNOSIS; STANDARD;

AGED; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 33750317870     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2412051866     Document Type: Article

References (46)

1. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000;164:400-404.
2. Salomon L, Colombel M, Patard JJ, et al. Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol 1999;35:289-293.
3. Salo JO, Rannikko S, Makinen J, Lehtonen T. Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 1987;10:1-9.
4. Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol 1994;132:2304-2307.
5. Jager GJ, Ruijter ET, van de Kaa CA, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 1996;166:845-852.
6. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 1999;213:473-480.
7. 3) spatial resolution. Radiology 1996;198:793-805.
8. Heerschap A, Jager GJ, van der Graaf M, et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 1997;17:1455-1460.
9. Scheenen TW, Klomp DW, Roll SA, Fütterer JJ, Barentsz JO, Heerschap A. Fast, acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn Reson Med 2004;52:80-88.
10. 1H MR spectroscopic imaging - initial results. Radiology 2003;229:241-247.
11. Donahue KM, Weisskoff RM, Parmelee DJ, et al. Dynamic Gd-DTPA enhanced MRI measurement, of tissue cell volume fraction. Magn Reson Med 1995;34:423-432.
12. Huisman HJ, Engelbrecht MR, Barentsz JO. Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 2001;13:607-614.
13. Kiessling F, Lichy M, Grobholz R, et al. Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI: value of two-compartment model [in German]. Radiologe 2003;43:474-480.
14. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000;55:99-109.
15. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003;229:248-254.
16. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 2004;233:709-715.
17. Jager GJ, Ruijter ET, van de Kaa CA, et al. Dynamic turboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997;203:645-652.
18. Ogura K, Maekawa S, Okubo K, Aoki Y, et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 2001;57:721-726.
19. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-384.
20. Hittmair K, Gomiscek G, Lanenberger K, Recht M, Imhof H. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571.
21. Kovar DA, Lewis M, Karczmar GS. A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging 1998;8:1126-1134.
22. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
23. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1993;193:385-390.
24. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004;233:701-708.
25. Scheenen TW, Weiland E, Fütterer JJ, et al. Preliminary results of IMAPS: an international multi-centre assessment of prostate MR spectroscopy [abstract]. In: Proceedings of the 13th Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2003.
26. Sobin LH, Wittekind C. TNM classification of malignant tumors. 5th ed. New York, NY: Wiley, 1997.
27. Dhingsa R, Qayyum A, Coakley FV, et al. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology 2004;230:215-220.
28. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittmore AS, Schmid HP. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993;71:933-938.
29. Augustin H, Hammerer PG, Graefen M, et al. Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction. Eur Urol 2003;43:455-460.
30. Rutter CM. Bootstrap estimation of diagnostic accuracy with patient-clustered data. Acad Radiol 2000;7:413-419.
31. Obuchowski NA, Lieber ML, Powell KA. Data analysis for detection and localization of multiple abnormalities with application to mammography. Acad Radiol 2000;7:516-323.
32. Pucar D, Shukla-Dave A, Hricak H, et al. Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. Radiology 2005;236:543-553.
33. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
34. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology 2003;226:24-28.
35. Chen ME, Johnston DA, Tang K, et al. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000;89:1800-1809.
36. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.
37. Coakley FV, Kurhanewicz J, Lu Y, et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002;223:91-97.
38. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234:804-814.
39. Chakraborty DP, Winter LH. Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology 1990;174:873-881.
40. Zheng B, Chakraborty DP, Rockette HE, Maitz GS, Gur D. A comparison of two data analyses from two observer performance studies using Jackknife ROC and JAFROC. Med Phys 2005;32:1031-1034.
41. Chakraborty DP, Berbaum KS. Observer studies involving detection and localization: modeling, analysis, and validation. Med Phys 2004;31:2313-2330.
42. Dodd LE, Wagner RF, McNitt-Gray MF, et al. Assessment methodologies and statistical issues for computer-aided diagnosis of lung nodules in computed tomography: contemporary research topics relevant to the lung image database consortium. Acad Radiol 2004;11:462-475.
43. Ponchietti R, Di Loro F, Fanfani A, Amorosi A. Estimation of prostate cancer volume by endorectal coil magnetic resonance imaging vs pathologic volume. Eur Urol 1999;35:32-35.
44. van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004;20:279-287.
45. Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004;183:1079-1083.
46. Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002;12:229-237.